Literature DB >> 3689658

Occurrence of a multidrug-resistant phenotype in human lung xenografts.

J Mattern1, M Bak, M Volm.   

Abstract

The intrinsic sensitivity of a panel of 8 human epidermoid lung cancer xenografts to vincristine and actinomycin D has been examined and the cross-resistance patterns of the most vincristine-resistant and vincristine-sensitive tumour line were tested to a variety of other drugs, including radiation. The results demonstrate that xenograft lines derived from human lung tumours not previously treated with chemotherapy exhibit a similar general pattern of cross-resistance to the drugs vincristine, actinomycin D and adriamycin as is observed in human cell lines and in animal models selected for resistance to these drugs. It is also shown that intrinsic resistance to vincristine can be partially overcome by verapamil. This may indicate a potential role of this substance in circumventing clinically observed drug resistance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689658      PMCID: PMC2001832          DOI: 10.1038/bjc.1987.215

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Rapid assays for evaluating the drug sensitivity of tumor cells.

Authors:  N T Bech-Hansen; F Sarangi; D J Sutherland; V Ling
Journal:  J Natl Cancer Inst       Date:  1977-07       Impact factor: 13.506

Review 2.  Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents.

Authors:  D Kessel
Journal:  Cancer Surv       Date:  1986

3.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies.

Authors:  J L Biedler; H Riehm
Journal:  Cancer Res       Date:  1970-04       Impact factor: 12.701

Review 4.  Genetic and biochemical characterization of multidrug resistance.

Authors:  J R Riordan; V Ling
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

Review 5.  Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.

Authors:  M T Bakowski; J C Crouch
Journal:  Cancer Treat Rev       Date:  1983-09       Impact factor: 12.111

Review 6.  Multidrug resistance.

Authors:  J H Gerlach; N Kartner; D R Bell; V Ling
Journal:  Cancer Surv       Date:  1986

7.  Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.

Authors:  D R Bell; J H Gerlach; N Kartner; R N Buick; V Ling
Journal:  J Clin Oncol       Date:  1985-03       Impact factor: 44.544

Review 8.  Evidence for multidrug-resistant cells in human tumor cell populations.

Authors:  R H Shoemaker; G A Curt; D N Carney
Journal:  Cancer Treat Rep       Date:  1983-10

9.  Growth of human bronchial carcinomas in nude mice.

Authors:  J Mattern; S Jäger; J Sonka; K Wayss; M Volm
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

10.  Cross-resistance to cytotoxic drugs in human glioma cell lines in culture.

Authors:  S Merry; S B Kaye; R I Freshney
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

View more
  3 in total

1.  Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.

Authors:  M A Smith; S Merry; J G Smith; S B Kaye
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

2.  Development of drug resistance in a human epidermoid lung carcinoma xenograft line.

Authors:  J Mattern; M Bak; K H Hoever; M Volm
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640

3.  Establishment of drug resistance in human gastric and colon carcinoma xenograft lines.

Authors:  T Satta; K Isobe; M Yamauchi; I Nakashima; S Akiyama; K Itou; T Watanabe; H Takagi
Journal:  Jpn J Cancer Res       Date:  1991-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.